Arrow, K. J. (1963): Uncertainty and the Welfare Economics of Medical Care. American Economic Review, 53(5): 941–973.

Arrow, K. J. (1963): Uncertainty and the Welfare Economics of Medical Care. American Economic Review, 53(5): 941–973.)| false
• Search Google Scholar
• Export Citation

Babiarz, K. S. – Eggleston, K. – Miller, G. – Zhang, Q. (2015): An Exploration of China’s Mortality Decline under Mao: A Provincial Analysis, 1950–80. Population Studies, 69(1): 39–56.

Babiarz, K. S. – Eggleston, K. – Miller, G. – Zhang, Q. (2015): An Exploration of China’s Mortality Decline under Mao: A Provincial Analysis, 1950–80. Population Studies, 69(1): 39–56.)| false
• Search Google Scholar
• Export Citation

Berndt, E. R. – Trusheim, M. R. (2017): The Information Pharms Race and Competitive Dynamics of Precision Medicine. Paper Presented at the National Bureau of Economic Research Conference on Economic Dimensions of Personalized and Precision Medicine, Santa Monica, CA, September, 2017.

Berndt, E. R. – Trusheim, M. R. (2017): The Information Pharms Race and Competitive Dynamics of Precision Medicine. Paper Presented at the National Bureau of Economic Research Conference on Economic Dimensions of Personalized and Precision Medicine, Santa Monica, CA, September, 2017.)| false
• Search Google Scholar
• Export Citation

Čatić, T. (2016): Market Access Pricing in Central and Eastern Europe: Practical Guide to Successful Reimbursement in Bosnia and Herzegovina. ISPOR Central & Eastern Europe Network Newsletter 4(1). Https://Www.Ispor.Org/Ceenetwork/Newsletter/2016/Guide-To-Successful-Reimbursement-Bosnia-Herzegovina-And-Ukraine.Pdf.

Čatić, T. (2016): Market Access Pricing in Central and Eastern Europe: Practical Guide to Successful Reimbursement in Bosnia and Herzegovina. ISPOR Central & Eastern Europe Network Newsletter4(1). Https://Www.Ispor.Org/Ceenetwork/Newsletter/2016/Guide-To-Successful-Reimbursement-Bosnia-Herzegovina-And-Ukraine.Pdf.)| false
• Search Google Scholar
• Export Citation

Cybulski, J. S. – Clements, J. – Prakash, M. (2014): Foldscope: Origami-Based Paper Microscope. Plos One 9(6): E98781.

Cybulski, J. S. – Clements, J. – Prakash, M. (2014): Foldscope: Origami-Based Paper Microscope. Plos One9(6): E98781.)| false
• Search Google Scholar
• Export Citation

Chernew, M. E. – Newhouse, J. P. (2012): Health Care Spending Growth. Handbook of Health Economics, 2: 1–43.

Chernew, M. E. – Newhouse, J. P. (2012): Health Care Spending Growth. Handbook of Health Economics, 2: 1–43.)| false
• Search Google Scholar
• Export Citation

Deaton, A. (2003): Health, Inequality, and Economic Development. Journal of Economic Literature, 41(1): 113–158.

Deaton, A. (2003): Health, Inequality, and Economic Development. Journal of Economic Literature, 41(1): 113–158.)| false
• Search Google Scholar
• Export Citation

Deaton, A. (2013): The Great Escape: Health, Wealth, and the Origins of Inequality. Princeton University Press.

Deaton, A. (2013): The Great Escape: Health, Wealth, and the Origins of Inequality. Princeton University Press.)| false
• Search Google Scholar
• Export Citation

Eggleston, K. (2016): Innovation, Shortage, and the Economics of Health Care Systems. In: Hámori, B. – Rosta, M. (eds): Constraints and Driving Forces in Economic Systems: Studies in Honour of János Kornai. Cambridge Scholars Publishing, pp. 15–29.

Eggleston, K. (2016): Innovation, Shortage, and the Economics of Health Care Systems. In: Hámori, B. – Rosta, M. (eds): Constraints and Driving Forces in Economic Systems: Studies in Honour of János Kornai. Cambridge Scholars Publishing, pp. 15–29.)| false
• Search Google Scholar
• Export Citation

European Medicines Agency (2017): Herceptin. EMA.Europa.Eu. (Last Updated April 19, 2017, accessed September 5, 2017. http://Www.Ema.Europa.Eu/Ema/Index.Jsp?Curl=Pages/Medicines/Human/Medicines/000278/Human_Med_000818.Jsp&Murl=Menus/Medicines/Medicines.Jsp&Mid=WC0b01ac058001d125).

Frye, J. E. (ed.) (2015): International Drug Price Indicator Guide. MSH.Org. July 2, 2015. (Accessed September 5, 2017. http://Apps.Who.Int/Medicinedocs/Documents/S21982en/S21982en.Pdf.)

Frye, J. E. (ed.) (2015): International Drug Price Indicator Guide. MSH.Org. July 2, 2015. (Accessed September 5, 2017. http://Apps.Who.Int/Medicinedocs/Documents/S21982en/S21982en.Pdf.))| false
• Search Google Scholar
• Export Citation

Gulácsi, L. – Orlewska, E. – Péntek, M. (2012): Health Economics and Health Technology Assessment in Central and Eastern Europe: A Dose of Reality. The European Journal of Health Economics, 13(5): 525–531. https://Link.Springer.Com/Article/10.1007%2Fs10198-012-0411-X.

Gulácsi, L. – Orlewska, E. – Péntek, M. (2012): Health Economics and Health Technology Assessment in Central and Eastern Europe: A Dose of Reality. The European Journal of Health Economics, 13(5): 525–531. https://Link.Springer.Com/Article/10.1007%2Fs10198-012-0411-X.)| false
• Search Google Scholar
• Export Citation

Hamburg, M. – Collins, F. (2010): The Path to Personalized Medicine. The New England Journal of Medicine, 363(4): 301–304.

Hamburg, M. – Collins, F. (2010): The Path to Personalized Medicine. The New England Journal of Medicine, 363(4): 301–304.)| false
• Search Google Scholar
• Export Citation

Kornai, J. – Eggleston, K. (2001): Welfare, Choice and Solidarity in Transition: Reforming the Health Sector in Eastern Europe. Cambridge, UK: Cambridge University Press.

Kornai, J. – Eggleston, K. (2001): Welfare, Choice and Solidarity in Transition: Reforming the Health Sector in Eastern Europe. Cambridge, UK: Cambridge University Press.)| false
• Search Google Scholar
• Export Citation

Kornai, J. (2013): Dynamism, Rivalry, and the Surplus Economy: Two Essays on the Nature of Capitalism. Oxford University Press.

Kornai, J. (2013): Dynamism, Rivalry, and the Surplus Economy: Two Essays on the Nature of Capitalism. Oxford University Press.)| false
• Search Google Scholar
• Export Citation

Management Sciences for Health (2014): Trastuzumab. Mshpriceguide.Org., January, 2014. (Accessed September 5, 2017. http://Mshpriceguide.Org/En/Single-Drug-Information/?Dmfid=147 1&Searchyear=2014).

Management Sciences for Health (2014): Trastuzumab. Mshpriceguide.Org., January, 2014. (Accessed September 5, 2017. http://Mshpriceguide.Org/En/Single-Drug-Information/?Dmfid=147 1&Searchyear=2014).)| false
• Search Google Scholar
• Export Citation

Mayor, S. (2016): Differences in Availability of Cancer Drugs across Europe. The Lancet Oncology, 17(9): 1196. http://Www.Thelancet.Com/Journals/Lanonc/Article/PIIS1470-2045(16)30378-3/Fulltext.

Mayor, S. (2016): Differences in Availability of Cancer Drugs across Europe. The Lancet Oncology, 17(9): 1196. http://Www.Thelancet.Com/Journals/Lanonc/Article/PIIS1470-2045(16)30378-3/Fulltext.)| false
• Search Google Scholar
• Export Citation

NCK Pharma Solution (2017): Mylan Settles Trastuzumab Patent Litigation with Genentech and Roche. Nckpharma.Com., March 15, 2017. (Accessed September 5, 2017. https://Nckpharma.Com/Index.Php/Mylan-Settles-Trastuzumab-Patent-Litigation-With-Genentech-And-Roche/).

NCK Pharma Solution (2017): Mylan Settles Trastuzumab Patent Litigation with Genentech and Roche. Nckpharma.Com., March 15, 2017. (Accessed September 5, 2017. https://Nckpharma.Com/Index.Php/Mylan-Settles-Trastuzumab-Patent-Litigation-With-Genentech-And-Roche/).)| false
• Search Google Scholar
• Export Citation

Neumann, P. J. – Ganiats, Th. G. – Russell, L. B. – Sanders, G. D. – Siegel, J. E. (2017) (eds): Cost Effectiveness in Health and Medicine. Oxford University Press.

Neumann, P. J. – Ganiats, Th. G. – Russell, L. B. – Sanders, G. D. – Siegel, J. E. (2017) (eds): Cost Effectiveness in Health and Medicine. Oxford University Press.)| false
• Search Google Scholar
• Export Citation

Nobelprize.Org. (2017): Youyou Tu –Facts. Nobel Media AB 2014. (Accessed: 12 Oct 2017, <http://Www.Nobelprize.Org/Nobel_Prizes/Medicine/Laureates/2015/Tu-Facts.Html>

Nobelprize.Org. (2017): Youyou Tu –Facts. Nobel Media AB 2014. (Accessed: 12 Oct 2017, <http://Www.Nobelprize.Org/Nobel_Prizes/Medicine/Laureates/2015/Tu-Facts.Html>)| false
• Search Google Scholar
• Export Citation

Ross-Degnan, D. – Lu, Ch. Y. – Chaiyakunapruk, N. – Wagner, A. K. (2015): Policies and Programs to Facilitate Access to Targeted Cancer Therapies in Thailand. PLOS ONE (2015). http://Journals.Plos.Org/Plosone/Article?Id=10.1371/Journal.Pone.0119945.

Ross-Degnan, D. – Lu, Ch. Y. – Chaiyakunapruk, N. – Wagner, A. K. (2015): Policies and Programs to Facilitate Access to Targeted Cancer Therapies in Thailand. PLOS ONE (2015). http://Journals.Plos.Org/Plosone/Article?Id=10.1371/Journal.Pone.0119945.)| false
• Search Google Scholar
• Export Citation

Singhroy, D. – Love, J. (2016): Proposal for the Inclusion of Trastuzumab Emtansine (T-Dm1) in the WHO Model List of Essential Medicines for the Treatment of HER2-Positive Locally Advanced or Metastatic Breast Cancer. Knowledge Ecology International, December, 2016. (Accessed September 5, 2017. http://Www.Who.Int/Selection_Medicines/Committees/Expert/21/ Applications/S8_Trastuzumab_Emtansine.Pdf?Ua=1).

Singhroy, D. – Love, J. (2016): Proposal for the Inclusion of Trastuzumab Emtansine (T-Dm1) in the WHO Model List of Essential Medicines for the Treatment of HER2-Positive Locally Advanced or Metastatic Breast Cancer. Knowledge Ecology International, December, 2016. (Accessed September 5, 2017. http://Www.Who.Int/Selection_Medicines/Committees/Expert/21/ Applications/S8_Trastuzumab_Emtansine.Pdf?Ua=1).)| false
• Search Google Scholar
• Export Citation

Wait, S. (2016): Access to Immuno-Oncology Therapies – European Policy Perspective. The American Journal of Managed Care, 20(2). http://Www.Ajmc.Com/Journals/Evidence-Based-Oncology/2016/February-2016/Access-To-Immuno-Oncology-Therapies-European-Policy-Perspective/P-1.

Wait, S. (2016): Access to Immuno-Oncology Therapies – European Policy Perspective. The American Journal of Managed Care, 20(2). http://Www.Ajmc.Com/Journals/Evidence-Based-Oncology/2016/February-2016/Access-To-Immuno-Oncology-Therapies-European-Policy-Perspective/P-1.)| false
• Search Google Scholar
• Export Citation

World Health Organization (2015): 19th WHO Model List of Essential Medicines. WHO.Int., April, 2015. (Accessed September 5, 2017. http://Www.Who.Int/Medicines/Publications/Essentialmedicines/ EML_2015_FINAL_Amended_NOV2015.Pdf?Ua=1).

World Health Organization (2015): 19th WHO Model List of Essential Medicines. WHO.Int., April, 2015. (Accessed September 5, 2017. http://Www.Who.Int/Medicines/Publications/Essentialmedicines/ EML_2015_FINAL_Amended_NOV2015.Pdf?Ua=1).)| false
• Search Google Scholar
• Export Citation

Xu, Ch. (2017): Capitalism and Socialism: A Review of Kornai’s Dynamism, Rivalry, and the Surplus Economy. Journal of Economic Literature, 55(1): 191–208.

Xu, Ch. (2017): Capitalism and Socialism: A Review of Kornai’s Dynamism, Rivalry, and the Surplus Economy. Journal of Economic Literature, 55(1): 191–208.)| false
• Search Google Scholar
• Export Citation